Vigonvita Life Sciences Co., Ltd. (2630)
Market Closed
12 Aug, 08:00
HKEX HKEX Primary 127. 70
HKD +11.4
+9.8022%
11.56B Market Cap
- P/E Ratio
- Div Yield
104,720 Volume
- Eps
116.3 HKD
Previous Close Want to track 2630 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Vigonvita Life Sciences Co., Ltd. (2630) Statistics
Valuation metrics
Market Cap 11.56B
Enterprise value 11.76B
Trailing P/E (ttm) -33.03
Forward P/E -
PEG ratio -
Price/Sales (ttm) 123.86
Price/Book (mrq) 24.55
Enterprise Value/Revenue 115.21
Enterprise Value/EBITDA -42.39
Overview
Shares outstanding 66.68M
Float 39.24M
Shares short -
% Held by insiders 0.72%
% Held by institutions -
Average volume (10 days) 45.88K
Average volume (90 days) 47.77K
Price summary
52-Week low 51
52-Week high 134.9
Beta -
50-Day moving average 84.14
200-Day moving average 88.21
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 0.79%
Operating margin -3.27%
Operational effectiveness
Return on assets -0.21%
Return on equity -1.24%
Income Statement
Revenue (ttm) 102.1M
Revenue per share (ttm) 0.67
Quarterly revenue growth (yoy) -
Gross profit (ttm) 80.68M
EBITDA -
Net income to common (ttm) -355.72M
Diluted EPS (ttm) -2.69
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) -
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 1.07%
Book value per share (mrq) 3.07
Cash Flow
Cash flow statement -178.68M
Levered free cash flow (LFCF) -355.72M
